Recommendations for the Use of Prolonged‐Release Fampridine in Patients with Multiple Sclerosis (MS)

Prolonged‐release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis. This statement provides a brief summary o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Preiningerova, Jana Lizrova, Baumhackl, Ulf, Csepany, Tunde, Czaplinski, Adam, Deisenhammer, Florian, Derfuss, Tobias, Fabjan, Tanja H., Fazekas, Franz, Fuchs, Siegrid, Havrdova, Eva, Ledinek, Alenka Horvath, Illes, Zsolt, Jazbec, Sasa Sega, Klimova, Eleonora, Komoly, Samuel, Kurca, Egon, Linnebank, Michael, Lisy, Lubomir, Mares, Jan, Prochazkova, Lubica, Csilla, Rozsa, Szilasiova, Jarmila, Stourac, Pavel, Talab, Radomir, Turcani, Peter, Vachova, Marta, Vecsei, Laszlo, Vodusek, David, Zapletalova, Olga, Berger, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2013
Assuntos:
Clinical Guidelines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493348/
https://ncbi.nlm.nih.gov/pubmed/23607697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados